EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

News | Heart Failure

February 25, 2022 – Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded ...

Home February 25, 2022
Home
News | Atrial Fibrillation

February 16, 2022 – A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart ...

Home February 16, 2022
Home
News | Pacemakers

February 16, 2022 – A revolutionary pacemaker that re-establishes the heart’s naturally irregular beat is set to be ...

Home February 16, 2022
Home
News | Pediatric Cardiology

February 15, 2022 — UC Davis pediatric electrophysiologist Dan Cortez placed two objects onto the table in front of ...

Home February 15, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 14, 2022 — Philips, a global leader in health technology, is supporting the American Heart Association’s multi ...

Home February 14, 2022
Home
News | Catheters
February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...
Home February 09, 2022
Home
News | Cardiovascular Clinical Studies
February 8, 2022  A new study is the first to show that a remote cognitive assessment could help with tracking patients ...
Home February 07, 2022
Home
By far the two biggest news items from January included the first pig heart transplant into a human patient at the University of Maryland Medical Center, and the FDA clearance of Novarti's inclisiran (Leqvio) twice annual dose injectable LDL lowering drug.
Feature | By Dave Fornell, DAIC Editor

February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

Home February 01, 2022
Home
The cardiovascular effects of long-hauler COVID in 2022
Feature | Coronavirus (COVID-19) | By Dave Fornell, DAIC Editor

By the end of the first year of the COVID-19 pandemic, there was a clear sign that some virus patients had longer ...

Home January 23, 2022
Home
News | EP Lab

January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...

Home January 14, 2022
Home
News | EP Lab

January 13, 2022 — Abbott received U.S. Food and Drug Administration (FDA) clearance for the EnSite X EP System with ...

Home January 13, 2022
Home
News | EP Lab

January 7, 2022 — Khaldoun Tarakji, M.D., M.P.H., associate section head of cardiac electrophysiology at the Heart ...

Home January 07, 2022
Home
News | EP Lab

January 5, 2022 — Stereotaxis announced a recent publication in Frontiers in Cardiovascular Medicine titled “Atrial ...

Home January 05, 2022
Home
News | Remote Monitoring

January 4, 2022 –  Remote patient monitoring and cardiac data management solutions vendor Implicity received U.S. Food ...

Home January 04, 2022
Home
The most popular stories in 2021 included several on impact of COVID-19 on cardiology, the use of the Carmat artificial heart, advances in pulsed field ablation in electrophysiology and the FDA cleanace of the first photon-counting CT scanner.
Feature

Here is a list of the top 25 stories in 2021 on the Diagnostic and Interventional Cardiology (DAIC) website based on ...

Home December 16, 2021
Home
Subscribe Now